U.S. Gas Utilities Stock News

NYSE:SBR
NYSE:SBROil and Gas

Sabine Royalty Trust (SBR) Cuts July Distribution, Is The Valuation Gap Too Wide?

Sabine Royalty Trust (SBR) recently announced a lower July 2026 cash distribution of $0.429150 per unit. The decrease is tied to weaker natural gas pricing, even as reported oil and gas production volumes increased. See our latest analysis for Sabine Royalty Trust. The distribution update comes as Sabine Royalty Trust trades at $73.11, with recent pressure reflected in a 1 month share price return of down 6.94% and a 3 month share price return of down 2.00%. The year to date share price...
NYSE:NIO
NYSE:NIOAuto

NIO (NIO) Stock Could Be 4% Overvalued On Record June Deliveries

NIO stock sits at an awkward spot today, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a price that is roughly in line with the market, while the broader valuation checks and a long term share price decline raise questions about how much upside is really left for investors after a difficult five year stretch. Over the past five years, NIO shares are down about 89.5%, which puts the recent rebound into context and suggests long term holders have seen a significant...
NYSE:AXS
NYSE:AXSInsurance

How Investors May Respond To AXIS Capital (AXS) Removal From The Russell 1000 Dynamic Index

In late June 2026, AXIS Capital Holdings Limited (NYSE: AXS) was removed from the Russell 1000 Dynamic Index, reflecting a reconfiguration of that benchmark’s constituents. This index removal may reshape how some institutional and index-linked investors gain exposure to AXIS, potentially altering trading patterns and ownership mix. We’ll now examine how AXIS’s removal from the Russell 1000 Dynamic Index may influence its investment narrative and future capital allocation story. Uncover...
NYSE:CWK
NYSE:CWKReal Estate

The Bull Case For Cushman & Wakefield (CWK) Could Change Following Russell Defensive Index Addition

In late June 2026, Cushman & Wakefield was added to the Russell 2000 Defensive and Russell 2000 Value-Defensive Indexes, while also securing new advisory and brokerage mandates and announcing senior leadership appointments in its Global Capital Markets platform. Together, these developments highlight how the firm is being repositioned by the market as a more defense-oriented real estate services provider with reinforced capital markets leadership. We’ll now examine how Cushman & Wakefield’s...
NYSE:ZIM
NYSE:ZIMShipping

New Asia–East Coast South America Route Could Be A Game Changer For ZIM Integrated Shipping Services (ZIM)

ZIM Integrated Shipping Services recently announced the upcoming launch of its ZIM Falcon Service (ZFS), an exclusive route connecting Asia and the East Coast of South America from September 2026, aimed at serving time-sensitive cargo and exporters in agricultural and industrial sectors. This new service tightens links between key East Coast South America ports and ZIM’s wider network, highlighting how tailored, faster transit offerings can reshape the company’s role on important trade...
NYSE:P
NYSE:PTech

3 AI Infrastructure Stocks Backed by Real Data Center Demand

AI Infrastructure Stocks sit at the crossroads of powerful themes investors are watching right now, from inflation and interest rate decisions to energy markets and data demand. While central banks weigh growth against price pressures and bond markets react to every new data point, the physical backbone of AI, including data centers, power, and connectivity, remains essential for a wide range of potential applications. This article highlights 3 stocks from the AI Infrastructure Stocks...
NasdaqGS:HAPN
NasdaqGS:HAPNConsumer Finance

Index Additions And Rebrand Could Be A Game Changer For Happen (HAPN)

In late June 2026, Happen, Inc. (formerly LendingClub Corporation, now trading as NasdaqGS:HAPN) completed a corporate rebrand and was added to the NASDAQ Composite Index and several Russell Growth benchmarks, including the Russell 2000 and Russell 3000 Growth indices. This combination of index inclusions and rebranding could broaden Happen’s institutional ownership base and analyst coverage as investors reassess the business under its new identity. Next, we’ll examine how Happen’s inclusion...
NasdaqGS:MGNI
NasdaqGS:MGNIMedia

Is Magnite (MGNI) Undervalued Following Its Addition To Russell Value Indices?

Magnite (MGNI) is back in focus after being added to several Russell value indices, including the Russell 2000 Value, 2500 Value, 3000 Value, 3000E Value, and Small Cap Comp Value benchmarks. See our latest analysis for Magnite. The recent additions to multiple Russell value indices come as Magnite's share price has gathered pace, with a 30 day share price return of 37.15% and a 90 day share price return of 71.40%. Over longer periods, the 1 year total shareholder return is down 16.92%, the 3...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

How Investors May Respond To Cognex (CGNX) Spotlight As IBD ‘Stock of the Day’

Recently, Cognex was named Investor’s Business Daily’s “Stock of the Day,” highlighting its machine vision and AI role in factory automation as it launches the OneVision cloud-to-edge vision platform. This attention is colliding with growing discussion that Cognex’s shares trade at a premium to several intrinsic value estimates, putting extra focus on whether its AI-enabled automation push can sustain that valuation. We’ll now examine how Cognex’s IBD spotlight and questions around its...
NYSE:ULS
NYSE:ULSProfessional Services

Index Additions and New Japan Lab Could Be A Game Changer For UL Solutions (ULS)

In late June 2026, UL Solutions Inc. (NYSE: ULS) was added to multiple Russell indices and opened its new Automotive Technology and Innovation Center in Toyota City, Japan, expanding its automotive electromagnetic compatibility testing capacity in one of the world’s largest vehicle markets. Together with its first certification for a hazardous-location inspection robot, these moves highlight UL Solutions’ expanding role in safety-critical testing for advanced vehicles and industrial...
NYSE:CF
NYSE:CFChemicals

3 Stocks to Watch if Inflation and Supply Chain Costs Stay High

Inflation is staying sticky, supply chains are still under strain and the reopening of the Strait of Hormuz has eased some pressure without removing the underlying risks. For investors, that mix can create both potential opportunity and additional pitfalls as energy, shipping and fertilizer costs ripple through earnings and pricing power. This article looks at three stocks exposed to these latest developments, two that may be positioned to benefit from persistent cost pressures and one that...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

Could Breakthrough T1D’s Backing Refocus MannKind’s (MNKD) Strategy Around Pediatric Inhaled Insulin?

MannKind Corporation recently announced it received a grant from Breakthrough T1D’s Industry Discovery and Development Partnership program to support the INHALE-1 clinical study of Afrezza, its ultra rapid-acting inhaled insulin, in newly diagnosed pediatric type 1 diabetes patients aged 10 to under 18. This external funding, coming shortly after Afrezza’s FDA approval for children as young as six, underscores growing support for inhaled insulin as a potential option in early pediatric...
NasdaqGM:ATRC
NasdaqGM:ATRCMedical Equipment

Is AtriCure (ATRC) Still Undervalued Following Its Russell Defensive Index Additions?

AtriCure (ATRC) has been added to both the Russell 2000 Growth-Defensive Index and the Russell 2000 Defensive Index, a classification change that can affect how funds and investors view and allocate to the stock. See our latest analysis for AtriCure. AtriCure’s recent index additions come after a sharp near term rebound, with a 1 month share price return of 16.57% and a 90 day share price return of 9.36%. This is occurring even though the year to date share price return is down 19.05% and the...
NasdaqGM:NAMS
NasdaqGM:NAMSBiotechs

NewAmsterdam Pharma (NAMS) Alzheimer’s Data Push Puts Fair Value Back In Focus

Alzheimer’s data presentation puts NewAmsterdam Pharma in focus NewAmsterdam Pharma (NasdaqGM:NAMS) is drawing attention after announcing plans to present new obicetrapib data at the Alzheimer’s Association International Conference, highlighting the drug’s potential role in early Alzheimer’s disease prevention. See our latest analysis for NewAmsterdam Pharma. At a share price of $34.83, NewAmsterdam Pharma has seen a 7-day share price return of 4.78% and a 30-day share price return of 6.61%...
NYSE:HIG
NYSE:HIGInsurance

Do Leadership Shifts at Hartford (HIG) Clarify or Complicate Its Underwriting Profitability Narrative?

Hartford Financial Services Group recently confirmed Dave Draper as chief underwriting officer for its UK operations and appointed Bertie Troughton as head of upstream energy, international, after Draper had served as interim CUO and previously led third-party lines. These leadership moves come as analysts anticipate a softer second-quarter 2026 earnings result, raising fresh questions about underwriting discipline and profitability amid higher claims and operating costs. Next, we will...
NYSE:ESS
NYSE:ESSResidential REITs

Will Strong West Coast Demand And Capital Returns Change Essex Property Trust's (ESS) Narrative?

In recent months, Essex Property Trust has benefited from robust West Coast rental demand, high occupancy, limited housing supply, and elevated home prices, while continuing to return cash to investors through dividend increases and share buybacks. An interesting angle is how the company’s push for operational efficiency and balance sheet strength is helping offset uneven rent growth and competitive pressures, particularly in softer markets like Seattle. We’ll now examine how strong West...
NYSE:FHN
NYSE:FHNBanks

Is First Horizon (FHN) A Bargain After Joining Two Russell Defensive Indexes?

First Horizon (FHN) has just been added to both the Russell 1000 Value-Defensive Index and the Russell 1000 Defensive Index, highlighting the stock for investors who track defensive, value-focused portfolios. See our latest analysis for First Horizon. First Horizon's share price has gained 5.9% over the past month and 10.8% over the past quarter to close at $25.68. Its 1 year total shareholder return of 19.9% and very large 3 year total shareholder return of about 7x suggest momentum has been...
NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

Is Dollar Tree (DLTR) Fairly Valued On Its $2.5b Buyback Plan?

Dollar Tree (DLTR) has stepped up its capital return plans, with the Board replenishing the company’s share repurchase authorization to a total of $2.5b, alongside recent governance changes and shifts in major shareholder ownership. See our latest analysis for Dollar Tree. The recent buyback announcement comes after a 30 day share price return of 13.53% and a 90 day share price return of 14.40%. The 1 year total shareholder return of 21.73% contrasts with weaker 3 year outcomes, suggesting...
NasdaqGS:RRR
NasdaqGS:RRRHospitality

Boyd Gaming Stock And 2 Nevada Picks Tied To AI Infrastructure Growth

Nevada is quietly turning into a test case for what happens when fast growing AI infrastructure, data centers, and lithium projects land in a state where the workforce is expanding and average hourly pay is rising. At the same time, traditional Las Vegas casino revenues are under pressure, which may push capital and talent toward other parts of the local economy. This article looks at 3 stocks exposed to these Nevada trends, all potentially benefiting from stronger professional services,...
NYSE:AMTM
NYSE:AMTMProfessional Services

Amentum Holdings (AMTM) Gains NASA COSMOS Role As Valuation Debate Comes Back Into View

Amentum Holdings (AMTM) stock is back in focus after the company, through its ASCEND joint venture with Aerodyne Industries, secured NASA’s Consolidated Spaceflight Mission Operations and Systems contract. See our latest analysis for Amentum Holdings. The COSMOS award appears to have shifted attention back to Amentum Holdings, with a 1-day share price return of 5.15% and 7-day share price return of 4.89% contrasting with a year to date share price decline of 30.31% and a 1-year total...
NasdaqGS:OCFC
NasdaqGS:OCFCBanks

US Regional Bank Stocks Worth Watching As Treasury Yields Rise

Rising U.S. debt levels, heavier Treasury issuance, and the prospect of higher yields are reshaping how investors think about risk, income and financial stability. Banks and asset managers can feel these shifts quickly, through funding costs, trading activity and client demand for fixed income products. For investors, this creates both potential opportunities and areas of caution as interest costs climb and fiscal questions grow louder. This article walks through three stocks from our...
NYSE:DE
NYSE:DEMachinery

Deere Stock And 2 Blue Chips Tied To Global Demand And US Market Strength

Global capital continues to seek the depth and liquidity of US markets, while the dollar’s role in trade and finance and a strong legal and innovation ecosystem keep the country at the center of global investing conversations. At the same time, rising deficits, talk of de-dollarization, and tougher global competition are front of mind for many investors. In that context, this article looks at how these forces connect to a curated set of large cap, financially solid US stocks, and highlights 3...
NYSE:ATO
NYSE:ATOGas Utilities

What Atmos Energy (ATO)'s $700 Million Infrastructure-Focused Debt Offering Means For Shareholders

On June 18, 2026, Atmos Energy announced a US$700 million public offering of 4.750% Senior Notes due 2032, with proceeds earmarked for general corporate purposes including infrastructure investment. This move highlights how Atmos is pairing long-term network upgrades with disciplined capital raising to support its established dividend profile and funding needs. Next, we’ll examine how this sizeable debt raise to fund infrastructure investment could influence Atmos Energy’s existing...
NasdaqGM:SION
NasdaqGM:SIONBiotechs

Is Sionna Therapeutics (SION) Undervalued Or Already Priced In As Index Changes Draw Focus?

Sionna Therapeutics (SION) is in focus after being removed from several Russell indexes, following a US$5.27 million stock sale by director Peter A. Thompson under a pre-arranged Rule 10b5-1 trading plan. See our latest analysis for Sionna Therapeutics. The share price of Sionna Therapeutics has moved to US$43.99, with a 1-day share price return of 5.64% and a 30-day share price return of 16.44%. The 1-year total shareholder return of 107.60% points to strong longer term momentum despite...